Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
about
Model organisms in the fight against muscular dystrophy: lessons from drosophila and ZebrafishImmortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.Epigenetic therapy for Friedreich ataxia"Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular DisordersHow do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.(CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis.Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.An engineered RNA binding protein with improved splicing regulation.Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology.Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients.Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases.
P2860
Q26991681-755DA155-76CD-4BAF-B03F-BB67FFA5B1CEQ33588075-5F764562-B690-4ECA-A3DC-8BB99245C413Q33588831-329D6543-86D8-49D3-9234-081F6F4E39D3Q35145526-B060EE0E-60CF-4EC6-950B-B8CEDC2EEF1BQ35180607-248FEA94-1F10-4BBE-B1DE-6C95890B6CD9Q37610585-83B6C8A1-F895-4365-AE53-1A202F568626Q38060527-925EA6CC-80AC-4E41-B1B8-2DD8A143D130Q38177257-F8ED4D54-3746-47AC-A284-884BE202BEDFQ38721747-9E7D28A0-FB3D-4DB9-B4A4-792C213B3A52Q40979450-2505F94A-3053-44D2-8CF3-D68A091816E3Q47224795-9DF24D64-7A18-42F7-9E8B-2C28862CC643Q49798217-8331B04E-8E9D-4C9B-9340-9C7217423EB4Q52887157-70136829-882F-4176-B240-24EF67B14325Q54262745-B888F514-21F2-4E71-9E0C-73CEC00D098EQ54365453-3F94BF99-6FEF-4C79-A8BF-30AB40A94629
P2860
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@en
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@nl
type
label
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@en
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@nl
prefLabel
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@en
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
@nl
P1433
P1476
Gain of RNA function in pathological cases: Focus on myotonic dystrophy
@en
P2093
P304
P356
10.1016/J.BIOCHI.2011.06.028
P577
2011-07-13T00:00:00Z